0
Signin
countryflagUS

18889881171

AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

ProSomnus Inc. Common Stock

Healthcare US OSA

0.0401USD
0.0001(0.25%)

Last update at 2024-05-15T13:30:00Z

Day Range

0.020.08
LowHigh

52 Week Range

0.346.25
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Income before tax -7.14532M -5.96976M -6.15535M
Minority interest - - -
Net income 3.30M -5.97741M -6.17302M
Selling general administrative 9.89M 4.46M 3.29M
Selling and marketing expenses 8.87M 5.78M 3.52M
Gross profit 10.27M 7.31M 4.12M
Reconciled depreciation 1.40M 0.83M 0.57M
Ebit -1.02551M -4.81489M -4.14799M
Ebitda -11.47549M -3.98732M -3.57472M
Depreciation and amortization -10.44998M 0.83M 0.57M
Non operating income net other 10.45M - -
Operating income -1.02551M -4.81489M -4.14799M
Other operating expenses 30.87M 18.89M 12.44M
Interest expense 6.12M 3.25M 2.01M
Tax provision 0.00000M 0.00765M 0.02M
Interest income - - -
Net interest income -6.11981M -3.24522M -2.00736M
Extraordinary items - - -
Non recurring - - -
Other items - - -
Income tax expense -10.44998M 0.00765M 0.02M
Total revenue 19.39M 14.07M 8.29M
Total operating expenses 21.74M 12.13M 8.28M
Cost of revenue 9.13M 6.76M 4.17M
Total other income expense net -6.11981M -1.15487M -2.00736M
Discontinued operations - - -
Net income from continuing ops -7.14532M -5.97741M -6.17302M
Net income applicable to common shares -7.14532M -5.97741M -6.17302M
Preferred stock and other adjustments - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Total assets 33.20M 7.64M 6.36M
Intangible assets - - -
Earning assets - - -
Other current assets 1.85M 0.15M 0.17M
Total liab 53.69M 60.86M 53.61M
Total stockholder equity -20.49443M -53.22086M -47.24816M
Deferred long term liab - - -
Other current liab 3.71M 0.33M 0.35M
Common stock 0.00160M 0.00246M 0.00242M
Capital stock 0.00160M 0.00246M 0.00242M
Retained earnings -210.79459M -203.64927M -197.67187M
Other liab 14.80M 0.06M 1.61M
Good will - - -
Other assets - 0.15M 0.06M
Cash 15.92M 1.50M 1.56M
Cash and equivalents - - -
Total current liabilities 7.09M 6.57M 4.83M
Current deferred revenue - 2.80M 1.85M
Net debt 16.98M 12.38M 8.31M
Short term debt 1.28M 2.48M 1.86M
Short long term debt - 1.56M 1.20M
Short long term debt total 32.90M 13.88M 9.86M
Other stockholder equity 157.10M 150.43M 150.42M
Property plant equipment 2.40M 3.36M 2.90M
Total current assets 21.25M 4.13M 3.40M
Long term investments - - -
Net tangible assets -20.49443M -53.22086M -47.24816M
Short term investments - - -
Net receivables 2.84M 2.10M 1.46M
Long term debt 24.01M 10.53M 7.08M
Inventory 0.64M 0.38M 0.21M
Accounts payable 2.10M 0.96M 0.77M
Total permanent equity - - -
Noncontrolling interest in consolidated entity - - -
Temporary equity redeemable noncontrolling interests - - -
Accumulated other comprehensive income - - -
Additional paid in capital - - -
Common stock total equity 0.00160M - -
Preferred stock total equity - - -
Retained earnings total equity -210.79459M - -
Treasury stock - - -
Accumulated amortization - - -
Non currrent assets other 0.26M 0.15M 0.06M
Deferred long term asset charges - - -
Non current assets total 11.95M 3.51M 2.96M
Capital lease obligations 8.89M 1.79M 1.58M
Long term debt total 24.01M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Investments -1.35366M -0.30130M -0.08544M
Change to liabilities 1.66M 0.18M 0.02M
Total cashflows from investing activities -1.35366M -0.30130M -0.08544M
Net borrowings 26.55M 4.88M 4.46M
Total cash from financing activities 26.01M 4.88M 4.46M
Change to operating activities -1.49537M 2.38M 1.43M
Net income -7.14532M -5.97741M -6.17302M
Change in cash 14.42M -0.05497M 0.59M
Begin period cash flow 1.50M 1.56M 0.97M
End period cash flow 15.92M 1.50M 1.56M
Total cash from operating activities -10.23891M -4.63493M -3.78469M
Issuance of capital stock 14.37M - -
Depreciation 1.40M 0.83M 0.57M
Other cashflows from investing activities - - -
Dividends paid - - -
Change to inventory -0.26118M -0.16784M -0.02510M
Change to account receivables -0.88302M -0.74571M 0.19M
Sale purchase of stock 6.13M - -
Other cashflows from financing activities 49.15M 23.22M 15.62M
Change to netincome -7.60089M -1.26994M 0.14M
Capital expenditures 1.35M 0.30M 0.09M
Change receivables -0.88302M - -
Cash flows other operating 3.42M - -
Exchange rate changes - - -
Cash and cash equivalents changes 14.42M - -
Change in working capital -1.49364M 1.64M 1.61M
Stock based compensation 2.16M 0.00471M 0.00529M
Other non cash items -5.16164M 0.85M 0.20M
Free cash flow -11.59257M -4.93624M -3.87013M

Fundamentals

  • Previous Close 0.04
  • Market Cap14.76M
  • Volume140350
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-19.36274M
  • Revenue TTM25.61M
  • Revenue Per Share TTM7.08
  • Gross Profit TTM 7.31M
  • Diluted EPS TTM-0.92

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OSA
ProSomnus Inc. Common Stock		 0.0001 0.25% 0.04 - - 0.55 - 1.67 -6.2879
ABT
Abbott Laboratories		 0.46 0.44% 105.05 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 2.14 0.64% 334.13 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 0.43 0.51% 85.15 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.185 0.25% 74.27 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolarygologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.

ProSomnus Inc. Common Stock

5860 West Las Positas Boulevard, Pleasanton, CA, United States, 94588

Key Executives

Name Title Year Born
Mr. Sung Kim Co-Founder & CTO NA
Ms. Mindy Hungerman Chief Financial Officer NA
Mr. Jerry Vogel VP of Sales NA
Mr. Len Liptak Co-Founder, CEO & Director NA
Dr. John E. Remmers M.D. Chief Scientist NA
Ms. Heather Whalen VP of Marketing Communications NA
Dr. Shouresh Charkhandeh D.D.S. Global Scientific Committee Chair NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).